VINZENZ GRUPPE
     
 

18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.

Beheshti, Mohsen, Hehenwarter, Lukas, Paymani, Zeinab, Rendl, Gundula, Imamovic, Larisa, Rettenbacher, Rupert, Tsybrovskyy, Oleksiy, Langsteger, Werner und Pirich, Christian (2018) 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients. European Journal of Nuclear Medicine and Molecular Imaging, 45 (10). pp. 1762-1771.

[thumbnail of 18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.] Text (18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients.)
2018 EJNMMI Beheshti Hehenwarter.pdf
Restricted to Nur registrierte Benutzer

Download (1MB)
Typ des Eintrags: Fachpublikation (peer reviewed)
Bereiche: Ordensklinikum Linz Barmherzige Schwestern > Nuklearmedizin
Benutzer: Prof. Werner Langsteger
Hinterlegungsdatum: 19 Mär 2019 11:42
Letzte Änderung: 19 Mär 2019 11:42
URI: https://eprints.vinzenzgruppe.at/id/eprint/8526

Actions (login required)

Eintrag anzeigen
Eintrag anzeigen